title: Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail.
abstract: In an urban jail population, 3 months of isoniazid and rifapentine (3HP) was associated with an 85% latent tuberculosis infection treatment completion rate compared with 18% in a standard 9-month isoniazid treatment group. Among the 91 patients who started 3HP therapy, there were 2 treatment discontinuations from adverse drug reactions.
authors.affiliation: Stanford University, School of Medicine.
authors.forename: Maria
authors.initials: M
authors.lastname: Juarez-Reyes
authors.affiliation: California Department of Public Health, Richmond.
authors.forename: Mark
authors.initials: M
authors.lastname: Gallivan
authors.affiliation: Custody Health Services, Santa Clara Valley Medical Center , San Jose, California.
authors.forename: Alexander
authors.initials: A
authors.lastname: Chyorny
authors.affiliation: Custody Health Services, Santa Clara Valley Medical Center , San Jose, California.
authors.forename: Linda
authors.initials: L
authors.lastname: O'Keeffe
authors.affiliation: California Department of Public Health, Richmond; Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Neha S
authors.initials: NS
authors.lastname: Shah
keywords: correctional healthcare; prevention; tuberculosis